Target
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Ligand
BDBM26623
Substrate
n/a
Meas. Tech.
Inhibition Assay
pH
7.5±n/a
IC50
5820.4±n/a nM
Comments
extracted
Citation
 Cho, HWu, YChoi, C Thiazolidinedione derivative and use thereof US Patent  US8637558 Publication Date 1/28/2014 
Target
Name:
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Synonyms:
15-PGDH | 15-hydroxyprostaglandin dehydrogenase [NAD+] | HPGD | PGDH1 | PGDH_HUMAN | Prostaglandin dehydrogenase 1 (15-PGDH) | SDR36C1
Type:
Enzyme
Mol. Mass.:
28974.46
Organism:
Homo sapiens (Human)
Description:
P15428
Residue:
266
Sequence:
MHVNGKVALVTGAAQGIGRAFAEALLLKGAKVALVDWNLEAGVQCKAALDEQFEPQKTLFIQCDVADQQQLRDTFRKVVDHFGRLDILVNNAGVNNEKNWEKTLQINLVSVISGTYLGLDYMSKQNGGEGGIIINMSSLAGLMPVAQQPVYCASKHGIVGFTRSAALAANLMNSGVRLNAICPGFVNTAILESIEKEENMGQYIEYKDHIKDMIKYYGILDPPLIANGLITLIEDDALNGAIMKITTSKGIHFQDYDTTPFQAKTQ
  
Inhibitor
Name:
BDBM26623
Synonyms:
(5Z)-5-[(4-methylphenyl)methylidene]-1,3-thiazolidine-2,4-dione | US8637558, 41 | thiazolidine-2,4-dione, 1a
Type:
Small organic molecule
Emp. Form.:
C11H9NO2S
Mol. Mass.:
219.26
SMILES:
Cc1ccc(C=C2SC(O)=NC2=O)cc1 |w:5.4,c:9|
Structure:
Search PDB for entries with ligand similarity: